CClinicalTrials.gg
CompletedNCT01207401Updated Jun 10, 2013Results posted

Paracervical Block Before Intrauterine Device (IUD) Insertion

An interventional study of Lidocaine in Pain Control for Intrauterine Device Insertions, sponsored by Northwestern University. Completed at 1 site in United States. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-06-10.

Sponsored by Northwestern University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

The purpose of this study is to evaluate if a paracervical block containing 1% lidocaine administered prior to IUD insertion reduces insertion pain. The hypothesis is that women receiving paracervical analgesia will experience less pain during IUD insertion than those who do not receive such analgesia.

02

Conditions studied

  • Pain Control for Intrauterine Device Insertions

Keywords

  • intrauterine device
  • local anesthetic
03

In context

Lead sponsor

Northwestern University is the lead sponsor of 1,396 studies on the registry; 199 are open to participants now.

Of its 102 completed or terminated interventional studies of FDA-regulated products, 73 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Women age 18 -50 years
  • A negative urine pregnancy test and clinically unlikely to be pregnant
  • Seeking an intrauterine device for any indication
  • Willing and able to sign an informed consent in English

Exclusion criteria

Exclusion Criteria:

  • History of a prior IUD successful insertion
  • Previous failed insertion of an IUD
  • Known copper allergy
  • Known levonorgestrel allergy
  • Known lidocaine allergy
  • Current cervicitis
  • Pelvic Inflammatory Disease (PID) within 3 months
  • Pregnancy within six weeks prior to IUD insertion
  • Uterine anomaly or distortion of the uterine cavity
  • Use of any other pain medication within 6 hours prior to IUD insertion
  • Use of misoprostol within 24 hours prior to IUD insertion
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Paracervical Block

    Drug: Lidocaine

  • No intervention
    No Paracervical Block

Interventions

  • DrugLidocaine

    1% Lidocaine

06

What researchers measure

Primary outcomes

  1. Median Visual Analogue Score Measuring Pain

    We asked participants to report their pain score on visual analogue scale (0mm=no pain and 100mm=worse pain possible) at the following time points: 1. Speculum placement 2. Tenaculum placement 3. Paracervical block administration(if subject is in this arm) 4. IUD insertion 5. Five minutes post procedure

    Time frame: 1) Speculum placement 2) Tenaculum placement 3) Paracervical block administration(if subject is in this arm) 4) IUD insertion 5) Five minutes post procedure

07

Results

Posted Jun 10, 2013

Participant flow

July 2010- February 2011, Northwestern Medical Faculty Foundation

Participant flow — Overall Study
MilestoneParacervical BlockNo Paracervical Block
Started2624
Completed2624
Not completed00

Outcome measures

PrimaryMedian Visual Analogue Score Measuring Pain

We asked participants to report their pain score on visual analogue scale (0mm=no pain and 100mm=worse pain possible) at the following time points: 1. Speculum placement 2. Tenaculum placement 3. Paracervical block administration(if subject is in this arm) 4. IUD insertion 5. Five minutes post procedure

Time frame:
1) Speculum placement 2) Tenaculum placement 3) Paracervical block administration(if subject is in this arm) 4) IUD insertion 5) Five minutes post procedure
Reported as:
Median · units on a scale
Median Visual Analogue Score Measuring Pain
units on a scaleParacervical BlockNo Paracervical Block
1) Speculum Placement12 ± 13.18.5 ± 12.9
2) Tenaculum Placement12 ± 21.828 ± 16.2
3) Paracervical Block administration40 ± 29.3NA (NA to NA)
4) IUD insertion24 ± 35.062 ± 27.5
5) 5 minutes post procedure12 ± 25.717 ± 18.4

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Paracervical Block—0/26 (0%)0/26 (0%)
No Paracervical Block—0/24 (0%)0/24 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Paracervical BlockNo Paracervical BlockTotal
<=18 years000
Between 18 and 65 years262450
>=65 years000
Age Continuous
Age Continuous(years)Paracervical BlockNo Paracervical BlockTotal
Mean31.9 ± 5.933.2 ± 6.232.6 ± 6.0
Sex: Female, Male
Sex: Female, Male(Participants)Paracervical BlockNo Paracervical BlockTotal
Female262450
Male000
Region of Enrollment
Region of Enrollment(participants)Paracervical BlockNo Paracervical BlockTotal
United States262450
08

Study locations

1 site
  • Northwestern Medical Faculty Foundation or Prentice Ambulatory Care Clinic
    Chicago, Illinois 60611, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 10, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01207401
Lead sponsor
Northwestern University
Responsible party
Jessica Kiley (Assistant Professor, Northwestern University) — Principal investigator
First posted
Sep 22, 2010
Start date
Jul 2010
Primary completion
Feb 2011
Completion
Feb 2011
Results posted
Jun 10, 2013
Last update
Jun 10, 2013

Study contacts

Jessica Kiley, MD MPH
principal investigator · Northwestern University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion